FindTrial
Sign In

Quantitative analysis of intratumor heterogeneity based on CT to predict lymph node metastasis in the lateral region of papillary thyroid carcinoma

CT-based Quantitative analysis of intratumor heterogeneity for predicting lateral cervical lymph node metastasis in papillary thyroid carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081539
Enrollment
Unknown
Registered
2024-03-04
Start date
2024-03-04
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Experimental group (Patients with lateral lymph node metastasis underwent enhanced CT):None
Control group (Patients without lateral lymph node metastasis underwent enhanced CT):None

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 71 Years

Inclusion criteria

Inclusion criteria: 1. The pathological diagnosis was papillary thyroid carcinoma; 2. The first surgical treatment; 3. Clinical data and enhanced CT image data were complete

Exclusion criteria

Exclusion criteria: 1. Pathological diagnosis of other types; 2. Previously received surgical treatment or microwave ablation therapy; 3. Incomplete enhanced CT examination

Design outcomes

Primary

MeasureTime frame
Area under the curve;—

Countries

China

Contacts

Public ContactTiefeng Shi

The Second Affiliated Hospital of Harbin Medical University

shitiefeng1970@163.com+86 139 3633 1006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026